Olmesartan Medoxomil and Hydrochlorothiazide (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Olmesartan Medoxomil and Hydrochlorothiazide drug offered from Teva Pharmaceuticals USA, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Olmesartan Medoxomil and Hydrochlorothiazide |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
Olmesartan Medoxomil and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olmesartan Medoxomil and Hydrochlorothiazide from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-7615_f3b39478-b4af-4dcd-9bca-8a56cadef0b5 |
| PRODUCT NDC: | 0093-7615 |
| APPLICATION NUMBER: | ANDA200532 |
Other OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
